Mintz Represents Granata Bio Corporation in Series A+ Funding Round
January 25, 2025
January 25, 2025
BOSTON, Massachusetts, Jan. 25 -- Mintz, a law firm, issued the following news release:
Mintz represented Granata Bio Corporation (Granata Bio), a biopharma company focused on invigorating the $3.6B global infertility medication market, in its $15M Series A+ funding round.
The funding round will support Granata Bio's efforts to explore new innovative assets in reproductive health and further strengthen its position as a leader within the reproductive health space. . . .
Mintz represented Granata Bio Corporation (Granata Bio), a biopharma company focused on invigorating the $3.6B global infertility medication market, in its $15M Series A+ funding round.
The funding round will support Granata Bio's efforts to explore new innovative assets in reproductive health and further strengthen its position as a leader within the reproductive health space. . . .